Cosibelimab
Product Specifications
CAS Number
2216751-26-5
Target
PD-1/PD-L1
Related Pathways
Immunology/Inflammation|||Apoptosis|||Cell Cycle/Checkpoint
Bioactivity
Cosibelimab (CK-301; TG-1501) is a fully human, high-affinity monoclonal antibody that inhibits PD-L1 by preventing its interaction with PD-1. Featuring a functional Fc domain, this compound effectively induces antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC), targeting and eliminating PD-L1+ cell lines, including lymphoma cells [1].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1432111-01 0.02 mg (E-Coli)
Recombinant Bacillus cereus Proline--tRNA ligase 2 (proS2)
Ask
View Details MBS1432111-02 0.02 mg (Yeast)
Recombinant Bacillus cereus Proline--tRNA ligase 2 (proS2)
Ask
View Details 
MBS1432111-03 0.1 mg (E-Coli)
Recombinant Bacillus cereus Proline--tRNA ligase 2 (proS2)
Ask
View Details MBS1432111-04 0.1 mg (Yeast)
Recombinant Bacillus cereus Proline--tRNA ligase 2 (proS2)
Ask
View Details 
MBS1432111-05 0.02 mg (Baculovirus)
Recombinant Bacillus cereus Proline--tRNA ligase 2 (proS2)
Ask
View Details MBS1432111-06 0.02 mg (Mammalian-Cell)
Recombinant Bacillus cereus Proline--tRNA ligase 2 (proS2)
Ask
View Details